NEW ORLEANS Noting that lung cancer is women's number one cancer killer, Loyola medical oncologist Dr. Kathy S. Albain will speak on the molecular differences in lung cancer between men and women, June 4, at the annual meeting of Women Against Lung Cancer, a Professional Alliance for Education and Research (WALC), at the Hilton New Orleans Riverside Hotel, Two Poydras Street, New Orleans.

"Lung cancer takes more women's lives than reproductive cancers and breast cancer combined," said Albain, WALC vice president and professor, division of hematology/oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Ill. "We must devote more resources to battling this devastating disease."

Albain is calling for more research funding targeted to examining why lung cancer is so deadly and why it affects men and women so differently.

"Cigarette smoke damages women's lungs more than men's lungs and lung cancer treatment affects women differently than men," said Albain, director, Breast Research Program; co-director of the multidisciplinary Breast Oncology Center; and director of the Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University Health System, Maywood, Ill.

Albain has been a principal or senior investigator for major national and international research into treating breast and lung cancer.

Women Against Lung Cancer (www.4WALC.org) was established in 2001 to educate the public and health care professionals about the magnitude of the lung cancer problem in women. WALC supports and encourages research in gender-related differences in the causes, treatments and prevention of lung cancer. WALC also mentors women health care professionals to pursue careers in lung cancer research.

The WALC board is composed of leading women oncology health care professionals in the United States and Canada, along with membe
'"/>

Contact: Joanne Swanson
jswanson@lumc.edu
708-216-2445
Loyola University Health System
3-Jun-2004

Page: 1 2
Related biology news :

1. Leader in cancer treatment and prevention research honored
2. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
3. Chemical derived from vitamin-E shows early promise as cancer drug
4. New molecular link key to cellular proteins involved in cancer progression, other diseases
5. Phase II trials of second-generation antisense cancer drug planned following successful early study
6. Trial shows which brain cancer patients benefit from temozolomide
7. Genetic differences might help distinguish thyroid cancers
8. Evidence builds for potential new cancer drug target
9. New sequence involved in DNA replication timing may aid in cancer detection
10. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
11. Cannabis may help combat cancer-causing herpes viruses